Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page presents Pfizer’s completed Phase 3 comparison of bevacizumab-Pfizer and reference bevacizumab, each combined with paclitaxel and carboplatin, for advanced non-squamous non-small-cell lung cancer. It also provides study outcomes, eligibility information, participating locations, publications, and links to study documents and data-sharing details.
    Difference
    100%
    Check dated 2026-11-11T01:51:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:05:21.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH-wide notice about terminology changes appears above the page, which continues to show a 403 error. The site revision number changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:12:01.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:18:40.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A 403 Forbidden error page now loads where the study record would be, replacing the usual content such as study details and contacts with an error screen. This indicates an access issue on the page, rendering the record temporarily unavailable to users.
    Difference
    17%
    Check dated 2026-09-23T01:14:21.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.6 to v3.7.0, indicating a back-end or template upgrade rather than a change to the study details shown on the page.
    Difference
    0.0%
    Check dated 2026-09-16T00:13:13.000Z thumbnail image

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.